These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 27587205)

  • 41. Heavy Cannabis Use Is Associated With Low Bone Mineral Density and an Increased Risk of Fractures.
    Sophocleous A; Robertson R; Ferreira NB; McKenzie J; Fraser WD; Ralston SH
    Am J Med; 2017 Feb; 130(2):214-221. PubMed ID: 27593602
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cannabis sativa allergy: looking through the fog.
    Decuyper II; Van Gasse AL; Cop N; Sabato V; Faber MA; Mertens C; Bridts CH; Hagendorens MM; De Clerck L; Rihs HP; Ebo DG
    Allergy; 2017 Feb; 72(2):201-206. PubMed ID: 27590896
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Normative Perceptions of Cannabis Use Among European University Students: Associations of Perceived Peer Use and Peer Attitudes With Personal Use and Attitudes.
    Dempsey RC; McAlaney J; Helmer SM; Pischke CR; Akvardar Y; Bewick BM; Fawkner HJ; Guillen-Grima F; Stock C; Vriesacker B; Van Hal G; Salonna F; Kalina O; Orosova O; Mikolajczyk RT
    J Stud Alcohol Drugs; 2016 Sep; 77(5):740-8. PubMed ID: 27588532
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Don't Worry, Be Happy: Endocannabinoids and Cannabis at the Intersection of Stress and Reward.
    Volkow ND; Hampson AJ; Baler RD
    Annu Rev Pharmacol Toxicol; 2017 Jan; 57():285-308. PubMed ID: 27618739
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Successful Treatment of Suspected Cannabinoid Hyperemesis Syndrome Using Haloperidol in the Outpatient Setting.
    Jones JL; Abernathy KE
    Case Rep Psychiatry; 2016; 2016():3614053. PubMed ID: 27597918
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization of peripheral cannabinoid receptor expression and clinical correlates in schizophrenia.
    Chase KA; Feiner B; Rosen C; Gavin DP; Sharma RP
    Psychiatry Res; 2016 Nov; 245():346-353. PubMed ID: 27591408
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Possible Therapeutic Doses of Cannabinoid Type 1 Receptor Antagonist Reverses Key Alterations in Fragile X Syndrome Mouse Model.
    Gomis-González M; Busquets-Garcia A; Matute C; Maldonado R; Mato S; Ozaita A
    Genes (Basel); 2016 Aug; 7(9):. PubMed ID: 27589806
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cannabis and development of dual diagnoses: A literature review.
    Hanna RC; Perez JM; Ghose S
    Am J Drug Alcohol Abuse; 2017 Jul; 43(4):442-455. PubMed ID: 27612527
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Alcohol, Cannabis, and Opioid Use Disorders, and Disease Burden in an Integrated Health Care System.
    Bahorik AL; Satre DD; Kline-Simon AH; Weisner CM; Campbell CI
    J Addict Med; 2017; 11(1):3-9. PubMed ID: 27610582
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High on Cannabis and Calcineurin Inhibitors: A Word of Warning in an Era of Legalized Marijuana.
    Hauser N; Sahai T; Richards R; Roberts T
    Case Rep Transplant; 2016; 2016():4028492. PubMed ID: 27595035
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Activation of cannabinoid CB1 receptor contributes to suppression of spinal nociceptive transmission and inhibition of mechanical hypersensitivity by Aβ-fiber stimulation.
    Yang F; Xu Q; Shu B; Tiwari V; He SQ; Vera-Portocarrero LP; Dong X; Linderoth B; Raja SN; Wang Y; Guan Y
    Pain; 2016 Nov; 157(11):2582-2593. PubMed ID: 27589093
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Drug Use Normalization: A Systematic and Critical Mixed-Methods Review.
    Sznitman SR; Taubman DS
    J Stud Alcohol Drugs; 2016 Sep; 77(5):700-9. PubMed ID: 27588528
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Promoting self-change in cannabis use disorder: Findings from a randomized trial.
    Schluter MG; Hodgins DC; Stea JN; Kilborn ML
    Front Psychiatry; 2022; 13():1015443. PubMed ID: 36483140
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Insights from individuals successfully recovered from cannabis use disorder: natural versus treatment-assisted recoveries and abstinent versus moderation outcomes.
    Hodgins DC; Stea JN
    Addict Sci Clin Pract; 2018 Jul; 13(1):16. PubMed ID: 30056804
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Thinking Beyond Legalization: The Case for Expanding Evidence-Based Options for Cannabis Use Disorder Treatment in Canada.
    Jutras-Aswad D; Le Foll B; Bruneau J; Wild TC; Wood E; Fischer B
    Can J Psychiatry; 2019 Feb; 64(2):82-87. PubMed ID: 30033757
    [No Abstract]   [Full Text] [Related]  

  • 56. A scoping review and meta-analysis of psychosocial and pharmacological treatments for cannabis and tobacco use among African Americans.
    Montgomery L; Robinson C; Seaman EL; Haeny AM
    Psychol Addict Behav; 2017 Dec; 31(8):922-943. PubMed ID: 29199844
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Changes in marijuana use symptoms and emotional functioning over 28-days of monitored abstinence in adolescent marijuana users.
    Jacobus J; Squeglia LM; Escobar S; McKenna BM; Hernandez MM; Bagot KS; Taylor CT; Huestis MA
    Psychopharmacology (Berl); 2017 Dec; 234(23-24):3431-3442. PubMed ID: 28900686
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Narrative Review of Psychological Cannabis Use Treatments with And Without Pharmaceutical Adjunct.
    Copeland J; Gates P; Pokorski I
    Curr Pharm Des; 2016; 22(42):6397-6408. PubMed ID: 27587205
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Psychological and psychosocial interventions for cannabis cessation in adults: a systematic review short report.
    Cooper K; Chatters R; Kaltenthaler E; Wong R
    Health Technol Assess; 2015 Jul; 19(56):1-130. PubMed ID: 26202542
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Psychotherapeutic interventions for cannabis abuse and/or dependence in outpatient settings.
    Denis C; Lavie E; Fatséas M; Auriacombe M
    Cochrane Database Syst Rev; 2006 Jul; (3):CD005336. PubMed ID: 16856093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.